Procurement Summary
Country : USA
Summary : Trastuzumab and Biosimilars
Deadline : 04 Jun 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 118566402
Document Ref. No. : 36E79725R0038
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Presolicitation NoticePresolicitation NoticePage 3 of 3Presolicitation Notice*=Required FieldPresolicitation NoticePage 1 of 3SUBJECT*Trastuzumab and Biosimilars GENERAL INFORMATIONCONTRACTING OFFICE S ZIP CODE*60141SOLICITATION NUMBER*36E79725R0038RESPONSE DATE/TIME/ZONE06-04-2025 2:30 PM CENTRAL TIME, CHICAGO, USAARCHIVE99 DAYS AFTER THE RESPONSE DATESET-ASIDEPRODUCT SERVICE CODE*6505NAICS CODE*325412PLACE OF PERFORMANCE POSTAL CODECOUNTRYCONTACT INFORMATIONCONTRACTING OFFICE ADDRESSDepartment of Veteran Affairs OPAL/ National Acquisition Center Building 37 1st Avenue, One block North of Cermak POINT OF CONTACT*Contract Specialist Anthony Di Crescenzoanthony.dicrescenzo@va.gov708-786-4984ADDITIONAL INFORMATIONAGENCY S URLURL DESCRIPTIONAGENCY CONTACT S EMAIL ADDRESSanthony.dicrescenzo@va.govEMAIL DESCRIPTIONAgency POC email DESCRIPTIONPRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0038 for an unrestricted procurement for Trastuzumab and Biosimilars, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79725R0038 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 21, 2025, with a tentative closing date of June 4, 2025...
Active Contract Opportunity
Notice ID : 36E79725R0038
Related Notice
Department/Ind. Agency : VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier : VETERANS AFFAIRS, DEPARTMENT OF
Office: NAC PHARMACEUTICALS (36E797)
General Information
Contract Opportunity Type: Presolicitation (Original)
Original Published Date: May 01, 2025 08:50 am CDT
Original Response Date: Jun 04, 2025 02:30 pm CDT
Inactive Policy: Manual
Original Inactive Date: Sep 11, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance:,
Documents
Tender Notice
36E79725R0038_1.docx